Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study

• Main Authors: Kei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, Santai Song, Reena Nair, Corazon A. Ngelangel, Anita Bustam, William H.H. Reece, Manfred Lehnert
• Other Authors: National Cancer Centre, Singapore
• Format: Article
• Published: 2018
• Subjects: Biochemistry, Genetics and Molecular Biology; Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/23004
• Institution: Mahidol University

Purpose: The purpose was to evaluate the activity and toxicity of split-dose paclitaxel or docetaxel in combination with gemcitabine in patients with metastatic breast cancer (MBC) who had previously received anthracyclines. Patients and methods: A total of 210 patients were randomly assigned to one...